Brown Brothers Harriman & Co’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-97
| Closed | -$2.1K | – | 1192 |
|
2023
Q3 | $2.1K | Hold |
97
| – | – | ﹤0.01% | 1098 |
|
2023
Q2 | $6.58K | Hold |
97
| – | – | ﹤0.01% | 1022 |
|
2023
Q1 | $45.4K | Hold |
97
| – | – | ﹤0.01% | 749 |
|
2022
Q4 | $39K | Hold |
97
| – | – | ﹤0.01% | 763 |
|
2022
Q3 | $32K | Hold |
97
| – | – | ﹤0.01% | 850 |
|
2022
Q2 | $26K | Sell |
97
-86
| -47% | -$23.1K | ﹤0.01% | 826 |
|
2022
Q1 | $55K | Hold |
183
| – | – | ﹤0.01% | 745 |
|
2021
Q4 | $65 | Hold |
183
| – | – | ﹤0.01% | 659 |
|
2021
Q3 | $47 | Hold |
183
| – | – | ﹤0.01% | 691 |
|
2021
Q2 | $122 | Hold |
183
| – | – | ﹤0.01% | 522 |
|
2021
Q1 | $159 | Hold |
183
| – | – | ﹤0.01% | 459 |
|
2020
Q4 | $170K | Hold |
183
| – | – | ﹤0.01% | 467 |
|
2020
Q3 | $189K | Hold |
183
| – | – | ﹤0.01% | 394 |
|
2020
Q2 | $186K | Hold |
183
| – | – | ﹤0.01% | 386 |
|
2020
Q1 | $159K | Hold |
183
| – | – | ﹤0.01% | 381 |
|
2019
Q4 | $197K | Hold |
183
| – | – | ﹤0.01% | 469 |
|
2019
Q3 | $170K | Hold |
183
| – | – | ﹤0.01% | 451 |
|
2019
Q2 | $207K | Hold |
183
| – | – | ﹤0.01% | 388 |
|
2019
Q1 | $249K | Hold |
183
| – | – | ﹤0.01% | 349 |
|
2018
Q4 | $212K | Hold |
183
| – | – | ﹤0.01% | 336 |
|
2018
Q3 | $279K | Hold |
183
| – | – | ﹤0.01% | 311 |
|
2018
Q2 | $287K | Hold |
183
| – | – | ﹤0.01% | 294 |
|
2018
Q1 | $212K | Hold |
183
| – | – | ﹤0.01% | 318 |
|
2017
Q4 | $217K | Hold |
183
| – | – | ﹤0.01% | 333 |
|
2017
Q3 | $247K | Buy |
+183
| New | +$247K | ﹤0.01% | 302 |
|